Rep. Jim Banks U.S. Representative for Indiana's 3rd District | Official U.S. House headshot
Rep. Jim Banks U.S. Representative for Indiana's 3rd District | Official U.S. House headshot
Jim Banks, U.S. Congressman for Indiana's 3rd district, issued a series of statements on April 3, 2025, regarding various issues ranging from trade policies to drug policy and corporate practices. Banks, who has represented Indiana’s 3rd District since 2017, addressed topics salient to his constituents and national audiences through social media posts.
In an April 3 tweet, Banks praised President Trump's trade agenda, noting its impact on domestic manufacturing. He stated, "The future will be stamped with Made in America thanks to President Trump’s trade agenda. Today’s announcement is great news for Indiana." This endorsement reflects his support for policies prioritizing American manufacturing.
On the same day, Banks addressed the issue of drug trafficking through an additional tweet, raising concerns about illegal drugs entering the state. He claimed, "Enough Fentanyl to kill the entire state of Indiana crossed our northern border last year. Not a big deal to the @indystar, apparently." The comment underscores the ongoing concern over the opioid crisis and its impact on Indiana.
Banks also critiqued corporate actions in a April 3 tweet regarding Stellantis' business decisions. He outlined the company's recent history, stating: "Let’s recap the past few years at Stellantis: 2023: Pledges $19 billion investment in US manufacturing; 2023: CEO gets a 56% raise; 2024: Delays manufacturing investments, spends billions on stock buybacks; 2024: CEO quits after making $100 million+; January 2025: Uses $250." His remarks highlight scrutiny over corporate governance and investment strategies.